| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,874,325 | 634,469 | 636,385 | 642,954 | | Cost of Revenue | (470,363) | 235,732 | 234,631 | 235,792 | | | Gross Profit | 2,344,688 | 398,737 | 401,754 | 407,162 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 448,275 | 120,742 | 109,845 | 101,924 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 1,517,430 | 128,552 | 127,572 | 128,796 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 378,983 | 149,443 | 164,337 | 176,442 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 142,575 | 7,635 | (1,818) | 15,517 | | Earnings Before Interest And Taxes | 388,345 | 157,078 | 162,519 | 191,959 | | Interest Expense | 140,422 | 44,937 | 52,032 | 53,446 | | Income Before Tax | 247,923 | 112,141 | 110,487 | 138,513 | | Income Tax Expense | 99,876 | 42,813 | 43,107 | 38,441 | | Minority Interest | (936) | 226 | (226) |
-
| | | | Net Income From Continuing Ops | 280,324 | 69,554 | 67,154 | 100,072 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 280,324 | 69,554 | 67,154 | 100,072 | | Preferred Stock And Other Adjustments | 524 | (524) |
-
|
-
| | | Net Income Applicable To Common Shares | $280,848 | $69,030 | $67,154 | $100,072 |
|
0.22% Nasdaq 0.00%
Income Statement
